2-chloro-n(6)cyclopentyladenosine has been researched along with n(6)-cyclohexyladenosine in 10 studies
| Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) | Studies (n(6)-cyclohexyladenosine) | Trials (n(6)-cyclohexyladenosine) | Recent Studies (post-2010) (n(6)-cyclohexyladenosine) |
|---|---|---|---|---|---|
| 252 | 0 | 43 | 555 | 0 | 33 |
| Protein | Taxonomy | 2-chloro-n(6)cyclopentyladenosine (IC50) | n(6)-cyclohexyladenosine (IC50) |
|---|---|---|---|
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.0024 | |
| Adenosine receptor A3 | Rattus norvegicus (Norway rat) | 0.0024 | |
| Adenosine receptor A2b | Rattus norvegicus (Norway rat) | 0.588 | |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | 0.588 | |
| Adenosine receptor A1 | Gallus gallus (chicken) | 0.0025 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (70.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobson, KA; van Galen, PJ; Williams, M | 1 |
| Cappellacci, L; Franchetti, P; Grifantini, M; Lucacchini, A; Marchetti, S; Martini, C; Mazzoni, MR; Trincavelli, L | 1 |
| Costanzi, S; Cristalli, G; IJzerman, AP; Kunzel, JK; Lorenzen, A; Stannek, C; Vittori, S; Volpini, R | 1 |
| Cappellacci, L; Franchetti, P; Graser, G; Grifantini, M; Jayaram, HN; Lavecchia, A; Petrelli, R; Saiko, P; Szekeres, T; Vita, P | 1 |
| Lucchi, R; Poli, A; Rosati, AM; Traversa, U | 1 |
| Hirawa, N; Ishii, M; Iwamoto, T; Kihara, M; Takagi, N; Toya, Y; Umemura, S | 1 |
| Jacobson, KA; Jiang, JL; Liang, BT; Stambaugh, K | 1 |
| de Jong, JW; de Jonge, R | 1 |
| Rosati, AM; Traversa, U | 1 |
| Berrino, L; Capuano, A; De Novellis, V; Filippelli, A; Mazzeo, F; Rossi, F; Stella, L; Vitelli, MR | 1 |
2 review(s) available for 2-chloro-n(6)cyclopentyladenosine and n(6)-cyclohexyladenosine
| Article | Year |
|---|---|
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
Topics: Adenosine; Animals; Humans; Models, Chemical; Receptors, Purinergic; Second Messenger Systems; Structure-Activity Relationship | 1992 |
Ischemic preconditioning--do we need more (pharmacological) experiments?
Topics: Adenosine; Animals; Blood Flow Velocity; Bradykinin; Coronary Vessels; Humans; Ischemic Preconditioning, Myocardial; Myocardial Ischemia; Norepinephrine; Purinergic P1 Receptor Agonists | 1997 |
8 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and n(6)-cyclohexyladenosine
| Article | Year |
|---|---|
2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adenylyl Cyclase Inhibitors; Animals; Brain; Cattle; Enzyme Inhibitors; In Vitro Techniques; Male; Membranes; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Testis | 1998 |
N-cycloalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists of the A(1) adenosine receptor.
Topics: Adenosine; Animals; Brain; Guanosine 5'-O-(3-Thiotriphosphate); Magnetic Resonance Spectroscopy; Phenethylamines; Purinergic P1 Receptor Agonists; Radioligand Assay; Rats; Tubercidin; Xanthines | 2000 |
Ribose-modified purine nucleosides as ribonucleotide reductase inhibitors. Synthesis, antitumor activity, and molecular modeling of N6-substituted 3'-C-methyladenosine derivatives.
Topics: Adenosine; Antineoplastic Agents; Cell Line, Tumor; Enzyme Inhibitors; Humans; Ribonucleotide Reductases; Ribose; Structure-Activity Relationship | 2008 |
Biochemical and pharmacological evidence for the presence of A1 but not A2a adenosine receptors in the brain of the low vertebrate teleost Carassius auratus (goldfish).
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Goldfish; Hydrogen-Ion Concentration; Mammals; Neurotransmitter Agents; Phenethylamines; Radioligand Assay; Receptors, Purinergic P1; Species Specificity; Temperature | 1995 |
Identification and characterization of adenosine A1 receptor-cAMP system in human glomeruli.
Topics: Adenosine; Binding, Competitive; Cyclic AMP; Humans; In Vitro Techniques; Kidney Glomerulus; Kinetics; Radioligand Assay; Receptors, Purinergic; Xanthines | 1993 |
A novel cardioprotective function of adenosine A1 and A3 receptors during prolonged simulated ischemia.
Topics: Adenosine; Animals; Cardiotonic Agents; Cell Hypoxia; Cells, Cultured; Chick Embryo; Dihydropyridines; Heart; Heart Ventricles; Myocardial Ischemia; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A3; Receptors, Purinergic P1; Xanthines | 1997 |
Mechanisms of inhibitory effects of zinc and cadmium ions on agonist binding to adenosine A1 receptors in rat brain.
Topics: Adenosine; Amino Acids, Sulfur; Animals; Binding, Competitive; Brain; Cadmium; Culture Media; Diethyl Pyrocarbonate; Dithionitrobenzoic Acid; Dithiothreitol; Histidine; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Sulfhydryl Compounds; Sulfhydryl Reagents; Tritium; Zinc | 1999 |
Interactive role of adenosine and dopamine in the opiate withdrawal syndrome.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Caffeine; Chromatography, High Pressure Liquid; Dopamine; Injections, Subcutaneous; Male; Microdialysis; Morphine; Pyrimidines; Rats; Rats, Wistar; Receptors, Dopamine; Substance Withdrawal Syndrome; Triazoles | 2003 |